- Raw materials
- Diagnostic agents
- 4-Fluorobenzylamine
Filters
Custom request?
Type
Production region
Qualifications
Country of origin
4-Fluorobenzylamine API Manufacturers & Suppliers
1 verified results
All 4-Fluorobenzylamine data. Full access. Full negotiation power
Commercial-scale Suppliers
All certificates
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
4-Fluorobenzylamine | GMP-certified suppliers
A medication that serves as an experimental benzene derivative for research applications, primarily investigated for potential benefits in disease modulation and pharmaceutical development.
Therapeutic categories
Product Snapshot
- 4-Fluorobenzylamine is classified as an oral small molecule compound
- It is primarily utilized in experimental therapeutic research and development applications
- This compound currently holds an experimental approval status with no formal regulatory approvals from FDA or EMA
Clinical Overview
Currently, 4-Fluorobenzylamine does not have established clinical indications or approved therapeutic applications. Its pharmacodynamic profile and mechanism of action have not been elucidated in the scientific literature or regulatory submissions. As such, its medical and pharmacological effects remain under investigation, limiting the compound to experimental and research contexts.
Regarding absorption, distribution, metabolism, and excretion (ADME) characteristics, no definitive data are available. The fluorine atom in the aromatic ring may influence metabolic stability and membrane permeability; however, specific metabolic pathways or elimination profiles are not documented. Safety and toxicity assessments have not been reported, highlighting the necessity for cautious handling and thorough evaluation in preclinical studies.
4-Fluorobenzylamine is of interest within chemical and pharmaceutical research due to its structural features, including the incorporation of fluorine, which can affect molecule interaction profiles and potential bioactivity. It is not currently associated with any marketed pharmaceutical products or recognized brand names.
From an API procurement perspective, sourcing 4-Fluorobenzylamine requires diligent verification of purity and quality parameters, given its experimental status. Material specifications should include precise characterization of chemical identity and absence of impurities, considering the sensitivity of fluorine-substituted compounds. Reliable suppliers must demonstrate compliance with Good Manufacturing Practices (GMP) and provide certificates of analysis to ensure the compound meets research-grade or regulatory-relevant standards.
Identification & chemistry
| Generic name | 4-Fluorobenzylamine |
|---|---|
| Molecule type | Small molecule |
| DrugBank ID | DB03243 |
Pharmacology
Targets
| Target | Organism | Actions |
|---|---|---|
| Trypsin-1 | Humans |
Formulation & handling
- 4-Fluorobenzylamine is a small molecule solid suitable for oral formulation due to moderate water solubility and lipophilicity.
- The compound's phenylmethylamine structure requires consideration of potential reactivity during synthesis and formulation processes.
- Stability and handling should account for potential sensitivity to moisture given its limited aqueous solubility.
Regulatory status
4-Fluorobenzylamine is a type of Diagnostic agents
Diagnostic agents are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) used in the field of medical diagnostics. These agents play a vital role in diagnosing various diseases and conditions by aiding in the visualization and identification of specific biomarkers or structures within the body.
Diagnostic agents encompass a wide range of substances, including contrast agents, radiopharmaceuticals, and imaging agents. Contrast agents are commonly used in medical imaging techniques such as X-rays, magnetic resonance imaging (MRI), and computed tomography (CT) scans. They enhance the visibility of certain tissues or organs, allowing healthcare professionals to detect abnormalities more accurately.
Radiopharmaceuticals are another type of diagnostic agent that combines a radioactive component with a pharmaceutical compound. These agents emit radiation that can be detected by specialized imaging equipment, enabling the visualization of metabolic processes and the identification of abnormal cellular activity.
Imaging agents are designed to target specific molecular structures or biomarkers within the body. They can be used to detect and visualize specific proteins, enzymes, or receptors associated with certain diseases or conditions. By targeting these specific biomarkers, imaging agents provide valuable information about the presence, location, and extent of a disease, aiding in diagnosis and treatment planning.
Overall, diagnostic agents are essential tools in modern medicine, facilitating accurate and timely diagnoses. These pharmaceutical APIs enable healthcare professionals to identify and monitor diseases at an early stage, leading to better patient outcomes and improved treatment strategies.
4-Fluorobenzylamine API manufacturers & distributors
Compare qualified 4-Fluorobenzylamine API suppliers worldwide. We currently have 1 companies offering 4-Fluorobenzylamine API, with manufacturing taking place in 1 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.
| Supplier | Type | Country | Product origin | Certifications | Portfolio |
|---|---|---|---|---|---|
| United Pharma Industries ... | Distributor | China | China | CoA | 12 products |
When sending a request, specify which 4-Fluorobenzylamine API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).
Use the list above to find high-quality 4-Fluorobenzylamine API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.
